↓ Skip to main content

Tolerance to alternative cyclooxygenase‐2 inhibitors in nonsteroidal anti‐inflammatory drug hypersensitive patients

Overview of attention for article published in Clinical and Translational Allergy, June 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

policy
1 policy source
twitter
4 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tolerance to alternative cyclooxygenase‐2 inhibitors in nonsteroidal anti‐inflammatory drug hypersensitive patients
Published in
Clinical and Translational Allergy, June 2013
DOI 10.1186/2045-7022-3-20
Pubmed ID
Authors

Wendy SJ Malskat, André C Knulst, Carla AFM Bruijnzeel-Koomen, Heike Röckmann

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) frequently cause adverse drug reactions. Many studies have shown that drugs which selectively inhibit the cyclooxygenase-2 enzyme (COX-2) are safe alternatives in the majority of patients. However, hypersensitivity reactions to COX-2 inhibitors have been published. Hardly any data are available regarding the safety of alternatives in case of COX-2 inhibitor hypersensitivity. We aimed to investigate the tolerance to COX-2 inhibitors in patients with non-selective NSAID hypersensitivity. Furthermore, in COX-2 hypersensitive patients tolerance of a second COX-2 inhibitor was investigated.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 6%
Italy 1 6%
Unknown 15 88%

Demographic breakdown

Readers by professional status Count As %
Other 3 18%
Student > Doctoral Student 2 12%
Student > Master 2 12%
Lecturer > Senior Lecturer 1 6%
Student > Ph. D. Student 1 6%
Other 3 18%
Unknown 5 29%
Readers by discipline Count As %
Medicine and Dentistry 11 65%
Agricultural and Biological Sciences 2 12%
Unknown 4 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 August 2014.
All research outputs
#7,204,326
of 25,371,288 outputs
Outputs from Clinical and Translational Allergy
#387
of 756 outputs
Outputs of similar age
#58,118
of 209,138 outputs
Outputs of similar age from Clinical and Translational Allergy
#7
of 23 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 756 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,138 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.